We just received data on a new analyst forecast for $VERA. Dina Ramadane from B of A Securities set a price target of 70.0 for VERA.
To track analyst ratings and price targets for $VERA, check out Quiver Quantitative's $VERA forecast page.
Should you buy $VERA?
Some analysts are better than others. To view the past performance of B of A Securities, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$VERA Price Targets
Multiple analysts have issued price targets for $VERA recently. We have seen 4 analysts offer price targets for $VERA in the last 6 months, with a median target of $89.5.
Here are some recent targets:
- Dina Ramadane from B of A Securities set a target price of $70.0 on 07/07/2026
- Gavin Clark-Gartner from Evercore ISI Group set a target price of $91.0 on 05/15/2026
- Andy Chen from Wolfe Research set a target price of $88.0 on 03/11/2026
- Arthur He from HC Wainwright & Co. set a target price of $110.0 on 03/02/2026
$VERA Insider Trading Activity
$VERA insiders have traded $VERA stock on the open market 14 times in the past 6 months. Of those trades, 0 have been purchases and 14 have been sales.
Here’s a breakdown of recent trading of $VERA stock by insiders over the last 6 months:
- MARSHALL FORDYCE (PRESIDENT AND CEO) has made 0 purchases and 8 sales selling 76,876 shares for an estimated $3,103,144.
- SEAN GRANT (CHIEF FINANCIAL OFFICER) sold 4,949 shares for an estimated $207,778
- JOSEPH R YOUNG (SVP, FINANCE, CHIEF ACCT OFFCR) sold 3,117 shares for an estimated $130,863
- DAVID LEE JOHNSON (Chief Operating Officer) sold 2,579 shares for an estimated $108,276
- WILLIAM D. TURNER (Chief Regulatory Officer) sold 2,187 shares for an estimated $91,818
- ROBERT BRENNER (Chief Medical Officer) sold 2,151 shares for an estimated $90,307
- LAURENCE MATTHEW SKELTON (Chief Commercial Officer) sold 1,582 shares for an estimated $66,418
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$VERA Hedge Fund Activity
We have seen 124 institutional investors add shares of $VERA stock to their portfolio, and 78 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- HOLOCENE ADVISORS, LP removed 1,307,393 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $50,864,124
- DEEP TRACK CAPITAL, LP added 1,284,932 shares (+45.5%) to their portfolio in Q1 2026, for an estimated $49,990,279
- EVERSEPT PARTNERS, LP removed 899,018 shares (-29.3%) from their portfolio in Q1 2026, for an estimated $34,976,295
- PRICE T ROWE ASSOCIATES INC /MD/ removed 887,946 shares (-16.3%) from their portfolio in Q1 2026, for an estimated $34,545,539
- VESTAL POINT CAPITAL, LP added 818,159 shares (+148.8%) to their portfolio in Q1 2026, for an estimated $31,830,475
- TRI LOCUM PARTNERS LP removed 805,689 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $31,345,330
- STATE STREET CORP added 687,038 shares (+25.7%) to their portfolio in Q1 2026, for an estimated $26,729,213
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
